Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

about

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Item

http://www.wikidata.org/entity/Q55407136

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@en

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@nl

type

Item

label

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@en

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@nl

prefLabel

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@en

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

@nl

P1476

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications

@en

P2093

Alessandro Gulino

http://www.w3.org/2001/XMLSchema#string

Beatrice Belmonte

http://www.w3.org/2001/XMLSchema#string

Cecilia Beatrice Chighizola

http://www.w3.org/2001/XMLSchema#string

Francesco Tedesco

http://www.w3.org/2001/XMLSchema#string

Paola Adele Lonati

http://www.w3.org/2001/XMLSchema#string

Paolo Macor

http://www.w3.org/2001/XMLSchema#string

Pier Luigi Meroni

http://www.w3.org/2001/XMLSchema#string

P2860

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.

Anticardiolipin and complement activation: relation to clinical symptoms.

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers.

P304

1388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01388

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Orietta Borghi

Maria Gerosa

P577

2018-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29971066

http://www.w3.org/2001/XMLSchema#string

P932

6018396

http://www.w3.org/2001/XMLSchema#string